Document Detail


Decreased mortality associated with statin treatment in patients with acute myocardial infarction and lymphotoxin-alpha C804A polymorphism.
MedLine Citation:
PMID:  23398946     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AIMS: We previously reported the association of single nucleotide polymorphisms in the lymphotoxin alpha (LTα) gene with susceptibility to acute myocardial infarction (AMI) and increased mortality after discharge. In the present study, we investigated whether the adverse effect of LTα C804A polymorphism on mortality could be pharmacologically modified by statin treatment after AMI. METHODS AND RESULTS: We conducted a multicenter study that included 3486 post-AMI patients between 1998 and 2008. During a median follow-up period of 1775 days, 247 deaths were recorded. The mortality rate was significantly higher in LTα 804A allele carriers compared to non-804A allele carriers (7.9% vs. 5.7%, p = 0.011). The LTα 804A allele was significantly associated with increased mortality for post-AMI patients not receiving statins (hazard ratio [HR]: 1.48, 95% confidence interval [CI]: 1.03-2.12, p = 0.034), but not for those receiving statins (HR: 1.22, 95% CI: 0.70-2.10, p = 0.486). In-vitro experimental analyses demonstrated that the LTα 804A polymorphic protein, 26Asn-LTα(3), induced monocyte-endothelial interaction and endoplasmic reticulum (ER) stress in cardiomyocytes more strongly than the LTα(3) 804C polymorphic protein 26Thr-LTα(3). However, the effects of both LTα(3) proteins were decreased and became comparable by the pretreatment of cells with pravastatin. CONCLUSION: LTα C804A polymorphism was associated with an increased risk of mortality for AMI patients, although this effect was masked in patients treated with statins. This finding is supported by the observed attenuation of 26Asn-LTα(3)-mediated monocyte-endothelial interaction and ER stress in cardiomyocytes treated with pravastatin. LTα C804A polymorphism may have potential as a novel therapeutic target for secondary prevention after AMI.
Authors:
Shinichiro Suna; Yasuhiko Sakata; Daisaku Nakatani; Keiji Okuda; Masahiko Shimizu; Masaya Usami; Sen Matsumoto; Masahiko Hara; Kouichi Ozaki; Hiroya Mizuno; Tetsuo Minamino; Seiji Takashima; Masami Nishino; Yasushi Matsumura; Hiroshi Takeda; Toshihiro Tanaka; Hiroshi Sato; Masatsugu Hori; Issei Komuro
Related Documents :
9354516 - Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury.
3341166 - Assessment of myocardial oxidative stress in patients after myocardial revascularization.
7228366 - Cardiac contusion in the patient with multiple injuries.
20813126 - Chemical characterization of lycium barbarum polysaccharides and their reducing myocard...
25020576 - P163stromal derived factor 1-a protects human heart tissue from simulated ischaemia-rep...
21831866 - Absorbed dose assessment of cardiac and other tissues around the cardiovascular system ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-25
Journal Detail:
Title:  Atherosclerosis     Volume:  -     ISSN:  1879-1484     ISO Abbreviation:  Atherosclerosis     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-2-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013. Published by Elsevier Ireland Ltd.
Affiliation:
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Errors in the estimation of wall shear stress by maximum Doppler velocity.
Next Document:  Transplanted Human Pancreatic Islets After Long-Term Insulin Independence.